This episode currently has no reviews.
Submit ReviewThe S&P and Dow eked out a gain on Monday but all indexes closed the quarter with significant losses. This as investors await the onset of President Trump’s tariffs and the announcement of reciprocal levies. Plus the FDA’s vaccine head abruptly resigned over the weekend. What that means for drug development in the U.S.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review